AngioDynamics names Eric Honroth CEO, effective Nov. 2, 2026

ANGO•2026-10-08

AngioDynamics named Eric Honroth president, CEO and board member, effective Nov. 2, 2026. Jim Clemmer will leave the board that day and shift to a consulting role.

1. Leadership change

Honroth previously served as global president of Life Science at Getinge. Clemmer will leave AngioDynamics’ board on Nov. 2, 2026, and shift to a consulting role.

AngioDynamics names Eric Honroth CEO, effective Nov. 2, 2026

1. Leadership change

Related News

US energy stocks gain as oil rallies on Middle East supply concerns, hurricane risks

Entegris coverage initiated at Stifel with buy rating; target price $200

SPAR Canada, ReposiTrak launch Touchless Retail merchandising program in Canada

Gilat DataPath wins over $8 million in U.S. Department of War SATCOM support orders

Data centers' 'flexible' power usage could save the grid billions. Can they scale?